ATE131049T1 - Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen. - Google Patents

Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen.

Info

Publication number
ATE131049T1
ATE131049T1 AT92105713T AT92105713T ATE131049T1 AT E131049 T1 ATE131049 T1 AT E131049T1 AT 92105713 T AT92105713 T AT 92105713T AT 92105713 T AT92105713 T AT 92105713T AT E131049 T1 ATE131049 T1 AT E131049T1
Authority
AT
Austria
Prior art keywords
oxindol
carboxamide derivatives
preparations containing
medicinal preparations
injectable medicinal
Prior art date
Application number
AT92105713T
Other languages
English (en)
Inventor
Walter Fries
Carl Joerg Pfitzner
Guenther Dr Pfaff
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Application granted granted Critical
Publication of ATE131049T1 publication Critical patent/ATE131049T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92105713T 1991-04-08 1992-04-02 Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen. ATE131049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4111306A DE4111306C2 (de) 1991-04-08 1991-04-08 Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind

Publications (1)

Publication Number Publication Date
ATE131049T1 true ATE131049T1 (de) 1995-12-15

Family

ID=6429052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92105713T ATE131049T1 (de) 1991-04-08 1992-04-02 Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen.

Country Status (7)

Country Link
EP (1) EP0508311B1 (de)
JP (1) JPH05112528A (de)
AT (1) ATE131049T1 (de)
DE (2) DE4111306C2 (de)
DK (1) DK0508311T3 (de)
ES (1) ES2082260T3 (de)
GR (1) GR3019127T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9405661A (pt) * 1993-01-22 1995-11-21 Pfizer Sal de lisina de 6-cloro-5-flúor-3-(2-tenoil)-2-oxindole-1-carboxamida
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
EP0923932B1 (de) * 1996-02-26 2011-06-29 Eisai R&D Management Co., Ltd. Zusammensetzung enthaltend ein antitumormittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Also Published As

Publication number Publication date
DK0508311T3 (da) 1996-03-18
GR3019127T3 (en) 1996-05-31
DE4111306C2 (de) 1994-06-01
DE69206460D1 (de) 1996-01-18
ES2082260T3 (es) 1996-03-16
DE4111306A1 (de) 1992-10-15
EP0508311A1 (de) 1992-10-14
DE69206460T2 (de) 1996-04-25
EP0508311B1 (de) 1995-12-06
JPH05112528A (ja) 1993-05-07

Similar Documents

Publication Publication Date Title
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
ATE310519T1 (de) Arzneizusammensetzungen enthaltend ascomyzinderivate
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
DE69525291D1 (de) Bisphosphonat und anti-Resorption Agentien, enthaltende Zusammensetzungen zur Hemmung der Knochenschwund
ATE224717T1 (de) Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin
IL106562A0 (en) Pharmaceutical and/or cosmetic compositions and the use thereof
DK0532595T3 (da) Farmakologisk anvendelse af visse cystinderivater
FI951789A0 (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE69216188T3 (de) Kosmetika und Pharmazeutika enthaltend Extensin
ATE131049T1 (de) Injizierbare 2-oxindol-1-carboxamidderivate enthaltende arzneizubereitungen.
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
DE69208913T2 (de) 2-Oxindol-1-carboxamidderivat enthaltendes Arzneimittel zur rektalen Verabreichung
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
DE69434010D1 (de) C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen
DE505608T1 (de) Alpha-ergocryptine enthaltende pharmazeutische zusammensetzungen mit nervenschuetzender wirkung.
DE69333895D1 (de) Pharmazeutische Zusammensetzungen enthaltend neue iso-Butenyl-substituierte Taxane
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee